Anandroan is a drug used to treat prostate cancer in men. It works by reducing the production of testosterone, which is responsible for stimulating the growth of cancer cells. This contributes to slowing the progression of the disease and controlling it effectively. This drug is used in advanced stages of the disease or as an adjuvant treatment after surgery or radiation therapy. It must be used under medical supervision with periodic follow-up to assess the response to treatment and monitor any potential side effects. It is recommended to adhere to the specified dose and not stop the drug suddenly to avoid complications.
Anandroan is one of the important and effective drugs in the treatment of hormonal prostate cancer.